Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Sells $240M in Senior Notes

NEW YORK (GenomeWeb News) – Bruker has sold $240 million worth of senior notes through a private placement, it said in a filing with the US Securities and Exchange Commission Thursday.

The firm sold four series of notes in the placement: $20 million of 3.16 percent Series 2012A Senior Notes, Tranche A, due Jan. 18, 2017; $15 million of 3.74 percent Series 2012A Senior Notes, Tranche B, due Jan. 18, 2019; $105 million of 4.31 percent Series 2012A Senior Notes, Tranche C, due Jan. 18, 2022; and $100 million of 4.46 percent Series 2012A Senior Notes, Tranche D, due Jan. 18, 2024.

Bruker noted that under the terms of the note purchase agreement it may sell additional senior notes up to an aggregate amount of $600 million.

It intends to use the proceeds to reduce outstanding debt under its revolving credit facilities and for general corporate purposes.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.